Gartner Inc (IT)
Return on equity (ROE)
| Dec 31, 2024 | Sep 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 1,232,798 | 1,014,234 | 797,228 | 882,466 | 930,649 | 924,185 | 931,067 | 807,799 | 760,344 | 735,664 | 801,975 | 793,560 | 703,808 | 571,907 | 355,748 | 266,745 | 214,839 | 239,263 | 287,592 | 233,290 |
| Total stockholders’ equity | US$ in thousands | 1,359,170 | 1,064,680 | 718,174 | 680,634 | 566,638 | 586,506 | 472,858 | 227,798 | -64,926 | -142,867 | 118,153 | 371,058 | 334,507 | 527,638 | 891,594 | 1,090,430 | 1,037,500 | 991,219 | 890,275 | 938,593 |
| ROE | 90.70% | 95.26% | 111.01% | 129.65% | 164.24% | 157.57% | 196.90% | 354.61% | — | — | 678.76% | 213.86% | 210.40% | 108.39% | 39.90% | 24.46% | 20.71% | 24.14% | 32.30% | 24.86% |
December 31, 2024 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $1,232,798K ÷ $1,359,170K
= 90.70%
Gartner Inc's return on equity (ROE) has shown significant fluctuations over the period observed. The ROE has ranged from as low as 20.71% in September 30, 2020, to a high of 678.76% in March 31, 2022.
The ROE increased steadily from December 31, 2019, onwards, reaching exceptionally high levels in the first half of 2022. Subsequently, there was a lack of data for the next three quarters, indicating possible reporting delays or changes in financial disclosure.
The ROE then declined gradually from its peak in March 31, 2022, but remained relatively high compared to earlier periods. By December 31, 2024, the ROE had dropped to 90.70%, still showing a relatively strong return for equity investors.
Overall, Gartner Inc's ROE trend suggests periods of exceptional profitability, followed by some moderation but maintaining healthy returns on equity compared to the earlier periods in the data provided.